BIM
ALXN
Bogle Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-35,646
| Closed | -$4M | – | 358 |
|
|
2020
Q2 | $4M | Sell |
35,646
-88,280
| -71% | -$9.91M | 0.67% | 62 |
|
|
2020
Q1 | $11.1M | Buy |
123,926
+98,926
| +396% | +$8.88M | 1.16% | 7 |
|
|
2019
Q4 | $2.7M | Buy |
+25,000
| New | +$2.7M | 0.25% | 119 |
|
|
2019
Q1 | – | Sell |
-68,758
| Closed | -$6.69M | – | 429 |
|
|
2018
Q4 | $6.69M | Buy |
+68,758
| New | +$6.69M | 0.52% | 79 |
|
|
2018
Q3 | – | Sell |
-113,589
| Closed | -$14.1M | – | 363 |
|
|
2018
Q2 | $14.1M | Buy |
+113,589
| New | +$14.1M | 1.02% | 17 |
|
|
2017
Q4 | – | Sell |
-66,351
| Closed | -$9.31M | – | 383 |
|
|
2017
Q3 | $9.31M | Buy |
+66,351
| New | +$9.31M | 0.63% | 68 |
|
|
2014
Q2 | – | Sell |
-3,900
| Closed | -$593K | – | 406 |
|
|
2014
Q1 | $593K | Buy |
+3,900
| New | +$593K | 0.04% | 296 |
|